Melody Noel Brown

Array ( [id] => 8430995 [patent_doc_number] => 20120252869 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-10-04 [patent_title] => 'TREATMENT OF SIRTUIN (SIRT) RELATED DISEASES BY INHIBITION OF NATURAL ANTISENSE TRANSCRIPT TO A SIRTUIN (SIRT)' [patent_app_type] => utility [patent_app_number] => 13/386057 [patent_app_country] => US [patent_app_date] => 2010-07-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 34681 [patent_no_of_claims] => 39 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13386057 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8516811 [patent_doc_number] => 20120316218 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-12-13 [patent_title] => 'SMALL NON-CODING REGULARTORY RNA\'s and METHODS FOR THEIR USE' [patent_app_type] => utility [patent_app_number] => 13/261142 [patent_app_country] => US [patent_app_date] => 2010-07-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 268 [patent_figures_cnt] => 268 [patent_no_of_words] => 29741 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13261142 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5975927 [patent_doc_number] => 20110070241 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-03-24 [patent_title] => 'METHODS FOR MODULATING IMMUNE RESPONSES TO AAV GENE THERAPY VECTORS' [patent_app_type] => utility [patent_app_number] => 12/827520 [patent_app_country] => US [patent_app_date] => 2010-06-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 17389 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0070/20110070241.pdf [firstpage_image] =>[orig_patent_app_number] => 12827520 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7818527 [patent_doc_number] => 20120065147 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-03-15 [patent_title] => 'USE OF THE GTPASE RAB27B TO DIAGNOSE AND TREAT POOR PROGNOSIS ESTROGEN-RECEPTOR-POSITIVE BREAST CANCER' [patent_app_type] => utility [patent_app_number] => 13/320729 [patent_app_country] => US [patent_app_date] => 2010-05-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 14970 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0065/20120065147.pdf [firstpage_image] =>[orig_patent_app_number] => 13320729 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8685142 [patent_doc_number] => 20130053426 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-02-28 [patent_title] => 'Composition For Delivery Of Genetic Material' [patent_app_type] => utility [patent_app_number] => 13/264485 [patent_app_country] => US [patent_app_date] => 2010-04-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 12191 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13264485 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7757154 [patent_doc_number] => 20120029054 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-02-02 [patent_title] => 'RNA Interference Mediated Inhibition of GATA Binding Protein 3 (GATA3) Gene Expression Using Short Intefering Nucleic Acid (siNA)' [patent_app_type] => utility [patent_app_number] => 13/255725 [patent_app_country] => US [patent_app_date] => 2010-03-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 39497 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0029/20120029054.pdf [firstpage_image] =>[orig_patent_app_number] => 13255725 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7670048 [patent_doc_number] => 20110319317 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-12-29 [patent_title] => 'TREATMENT OF SIRTUIN 1 (SIRT1) RELATED DISEASES BY INHIBITION OF NATURAL ANTISENSE TRANSCRIPT TO SIRT1' [patent_app_type] => utility [patent_app_number] => 13/254600 [patent_app_country] => US [patent_app_date] => 2010-03-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 25 [patent_figures_cnt] => 25 [patent_no_of_words] => 34224 [patent_no_of_claims] => 40 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13254600 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8251890 [patent_doc_number] => 20120156216 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-06-21 [patent_title] => 'Methods and Compositions for Treatment of Tumor Metastasis' [patent_app_type] => utility [patent_app_number] => 13/254709 [patent_app_country] => US [patent_app_date] => 2010-03-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 10225 [patent_no_of_claims] => 53 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0156/20120156216.pdf [firstpage_image] =>[orig_patent_app_number] => 13254709 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10032902 [patent_doc_number] => 09074210 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-07-07 [patent_title] => 'Treatment of brain derived neurotrophic factor (BDNF) related diseases by inhibition of natural antisense transcript to BDNF' [patent_app_type] => utility [patent_app_number] => 13/201254 [patent_app_country] => US [patent_app_date] => 2010-02-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 7 [patent_no_of_words] => 26814 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 111 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13201254 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7580987 [patent_doc_number] => 20110294870 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-12-01 [patent_title] => 'TREATMENT OF TUMOR SUPPRESSOR GENE RELATED DISEASES BY INHIBITION OF NATURAL ANTISENSE TRANSCRIPT TO THE GENE' [patent_app_type] => utility [patent_app_number] => 13/133039 [patent_app_country] => US [patent_app_date] => 2009-12-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 88 [patent_figures_cnt] => 88 [patent_no_of_words] => 28484 [patent_no_of_claims] => 43 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13133039 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7490691 [patent_doc_number] => 20110237649 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-09-29 [patent_title] => 'TREATMENT OF SIRTUIN 1 (SIRT1) RELATED DISEASES BY INHIBITION OF NATURAL ANTISENSE TRANSCRIPT TO SIRTUIN 1' [patent_app_type] => utility [patent_app_number] => 13/132987 [patent_app_country] => US [patent_app_date] => 2009-12-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 26 [patent_figures_cnt] => 26 [patent_no_of_words] => 27889 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0237/20110237649.pdf [firstpage_image] =>[orig_patent_app_number] => 13132987 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8606534 [patent_doc_number] => 20130011845 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-01-10 [patent_title] => 'MICRORNA REGULATING THE INSULIN SIGNALING PATHWAY, AND METHOD FOR SCREENING MATERIAL FOR CONTROLLING THE ACTION OF A TARGET THEREOF' [patent_app_type] => utility [patent_app_number] => 13/513425 [patent_app_country] => US [patent_app_date] => 2009-12-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 35 [patent_figures_cnt] => 35 [patent_no_of_words] => 19453 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13513425 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7586761 [patent_doc_number] => 20110281271 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-11-17 [patent_title] => 'Oligoribonucleotide or Peptide Nucleic Acid Capable of Inhibiting Activity of Hepatitis C Virus' [patent_app_type] => utility [patent_app_number] => 13/130673 [patent_app_country] => US [patent_app_date] => 2009-11-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 11870 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0281/20110281271.pdf [firstpage_image] =>[orig_patent_app_number] => 13130673 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7566971 [patent_doc_number] => 20110287034 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-11-24 [patent_title] => 'THERAPEUTIC AND DIAGNOSTIC METHODS RELATING TO CANCER STEM CELLS' [patent_app_type] => utility [patent_app_number] => 13/128915 [patent_app_country] => US [patent_app_date] => 2009-11-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 35025 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 13 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0287/20110287034.pdf [firstpage_image] =>[orig_patent_app_number] => 13128915 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7487462 [patent_doc_number] => 20110236393 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-09-29 [patent_title] => 'MONOCLONAL ANTIBODY PRODUCTION IN B CELLS AND USES THEROF' [patent_app_type] => utility [patent_app_number] => 13/127627 [patent_app_country] => US [patent_app_date] => 2009-11-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 32894 [patent_no_of_claims] => 93 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0236/20110236393.pdf [firstpage_image] =>[orig_patent_app_number] => 13127627 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7579819 [patent_doc_number] => 20110293702 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-12-01 [patent_title] => 'Compounds and Methods for the Treatment of Inflammatory Diseases of the CNS' [patent_app_type] => utility [patent_app_number] => 13/127190 [patent_app_country] => US [patent_app_date] => 2009-11-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 20 [patent_no_of_words] => 11132 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0293/20110293702.pdf [firstpage_image] =>[orig_patent_app_number] => 13127190 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7586424 [patent_doc_number] => 20110280934 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-11-17 [patent_title] => 'Increased Expression of Specific Antigens' [patent_app_type] => utility [patent_app_number] => 13/127288 [patent_app_country] => US [patent_app_date] => 2009-11-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 11282 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0280/20110280934.pdf [firstpage_image] =>[orig_patent_app_number] => 13127288 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8465762 [patent_doc_number] => 20120270930 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-10-25 [patent_title] => 'METHODS AND COMPOSITIONS FOR DYSFERLIN EXON-SKIPPING' [patent_app_type] => utility [patent_app_number] => 13/504907 [patent_app_country] => US [patent_app_date] => 2009-10-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 17437 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13504907 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7766105 [patent_doc_number] => 20120034192 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-02-09 [patent_title] => 'COMPOSITIONS AND METHODS FOR ENHANCING CELL REPROGRAMMING' [patent_app_type] => utility [patent_app_number] => 13/119891 [patent_app_country] => US [patent_app_date] => 2009-09-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 23339 [patent_no_of_claims] => 66 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0034/20120034192.pdf [firstpage_image] =>[orig_patent_app_number] => 13119891 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 14172143 [patent_doc_number] => 10260070 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2019-04-16 [patent_title] => Aptamer for NGF and use thereof [patent_app_type] => utility [patent_app_number] => 13/120650 [patent_app_country] => US [patent_app_date] => 2009-09-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 17023 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 173 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13120650 [rel_patent_id] =>[rel_patent_doc_number] =>)